Literature DB >> 11500426

Adherent invasive Escherichia coli strains from patients with Crohn's disease survive and replicate within macrophages without inducing host cell death.

A L Glasser1, J Boudeau, N Barnich, M H Perruchot, J F Colombel, A Darfeuille-Michaud.   

Abstract

Escherichia coli strains recovered from Crohn's disease (CD) lesions are able to adhere to and invade cultured intestinal epithelial cells. We analyzed the behavior within macrophages of adherent invasive E. coli (AIEC) strains isolated from patients with CD. All the 15 AIEC strains tested were able to replicate extensively within J774-A1 cells: the numbers of intracellular bacteria increased 2.2- to 74.2-fold at 48 h over that at 1 h postinfection. By use of murine peritoneal macrophages and human monocyte-derived-macrophages, the reference AIEC strain LF82 was confirmed to be able to survive intracellularly. Transmission electron micrographs of AIEC LF82-infected macrophages showed that at 24 h postinfection, infected cells harbored large vacuoles containing numerous bacteria, as a result of the fusion of several vacuoles occurring after 8 h postinfection. No lactate dehydrogenase (LDH) release, no sign of DNA fragmentation or degradation, and no binding to fluorescein isothlocyanate-labeled annexin V were observed with LF82-infected J774-A1 cells, even after 24 h postinfection. LF82-infected J774-A1 cells secreted 2.7-fold more tumor necrosis factor alpha (TNF-alpha) than cells stimulated with 1 microg of lipopolysaccharide (LPS)/ml. No release of interleukin-1beta was observed with LPS-prestimulated J774-A1 cells infected with AIEC LF82. These findings showed that (i) AIEC strains are able to survive and to replicate within macrophages, (ii) AIEC LF82 replication does not induce any cell death of the infected cells, and (iii) LF82-infected J774-A1 cells release high levels of TNF-alpha. These properties could be related to some features of CD and particularly to granuloma formation, one of the hallmarks of CD lesions.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11500426      PMCID: PMC98666          DOI: 10.1128/IAI.69.9.5529-5537.2001

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  40 in total

Review 1.  Pathogen-induced apoptosis of macrophages: a common end for different pathogenic strategies.

Authors:  W W Navarre; A Zychlinsky
Journal:  Cell Microbiol       Date:  2000-08       Impact factor: 3.715

2.  Invasive ability of an Escherichia coli strain isolated from the ileal mucosa of a patient with Crohn's disease.

Authors:  J Boudeau; A L Glasser; E Masseret; B Joly; A Darfeuille-Michaud
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

3.  Expression of host resistance to Salmonella typhi and Salmonella typhimurium: bacterial survival within macrophages of murine and human origin.

Authors:  I R Vladoianu; H R Chang; J C Pechère
Journal:  Microb Pathog       Date:  1990-02       Impact factor: 3.738

4.  The Salmonella virulence plasmid spv genes are required for cytopathology in human monocyte-derived macrophages.

Authors:  S J Libby; M Lesnick; P Hasegawa; E Weidenhammer; D G Guiney
Journal:  Cell Microbiol       Date:  2000-02       Impact factor: 3.715

5.  Gliotoxin induces apoptosis in macrophages unrelated to its antiphagocytic properties.

Authors:  P Waring; R D Eichner; A Müllbacher; A Sjaarda
Journal:  J Biol Chem       Date:  1988-12-05       Impact factor: 5.157

Review 6.  Macrophage activation, chronic inflammation and gastrointestinal disease.

Authors:  A R Tanner; M J Arthur; R Wright
Journal:  Gut       Date:  1984-07       Impact factor: 23.059

7.  Type 1 pili-mediated adherence of Escherichia coli strain LF82 isolated from Crohn's disease is involved in bacterial invasion of intestinal epithelial cells.

Authors:  J Boudeau; N Barnich; A Darfeuille-Michaud
Journal:  Mol Microbiol       Date:  2001-03       Impact factor: 3.501

8.  Genetically related Escherichia coli strains associated with Crohn's disease.

Authors:  E Masseret; J Boudeau; J F Colombel; C Neut; P Desreumaux; B Joly; A Cortot; A Darfeuille-Michaud
Journal:  Gut       Date:  2001-03       Impact factor: 23.059

9.  Involvement of a plasmid in the invasive ability of Shigella flexneri.

Authors:  P J Sansonetti; D J Kopecko; S B Formal
Journal:  Infect Immun       Date:  1982-03       Impact factor: 3.441

10.  Intracellular survival of wild-type Salmonella typhimurium and macrophage-sensitive mutants in diverse populations of macrophages.

Authors:  N A Buchmeier; F Heffron
Journal:  Infect Immun       Date:  1989-01       Impact factor: 3.441

View more
  149 in total

Review 1.  Potential role of chitinases and chitin-binding proteins in host-microbial interactions during the development of intestinal inflammation.

Authors:  H T Tran; N Barnich; E Mizoguchi
Journal:  Histol Histopathol       Date:  2011-11       Impact factor: 2.303

2.  Inhibition of apoptosis by Escherichia coli K1 is accompanied by increased expression of BclXL and blockade of mitochondrial cytochrome c release in macrophages.

Authors:  Sunil K Sukumaran; Suresh K Selvaraj; Nemani V Prasadarao
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

3.  Increased rate of apoptosis and diminished phagocytic ability of human neutrophils infected with Afa/Dr diffusely adhering Escherichia coli strains.

Authors:  Patrick Brest; Frédéric Bétis; Nicolas Cuburu; Eric Selva; Magali Herrant; Alain Servin; Patrick Auberger; Paul Hofman
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

Review 4.  IBD-what role do Proteobacteria play?

Authors:  Indrani Mukhopadhya; Richard Hansen; Emad M El-Omar; Georgina L Hold
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-02-21       Impact factor: 46.802

Review 5.  Crohn disease: a current perspective on genetics, autophagy and immunity.

Authors:  Thaddeus S Stappenbeck; John D Rioux; Atsushi Mizoguchi; Tatsuya Saitoh; Alan Huett; Arlette Darfeuille-Michaud; Tom Wileman; Noboru Mizushima; Simon Carding; Shizuo Akira; Miles Parkes; Ramnik J Xavier
Journal:  Autophagy       Date:  2011-04-01       Impact factor: 16.016

Review 6.  Enteric Glial Cells: A New Frontier in Neurogastroenterology and Clinical Target for Inflammatory Bowel Diseases.

Authors:  Fernando Ochoa-Cortes; Fabio Turco; Andromeda Linan-Rico; Suren Soghomonyan; Emmett Whitaker; Sven Wehner; Rosario Cuomo; Fievos L Christofi
Journal:  Inflamm Bowel Dis       Date:  2016-02       Impact factor: 5.325

Review 7.  The epidemiology and risk factors of inflammatory bowel disease.

Authors:  Yulan Ye; Zhi Pang; Weichang Chen; Songwen Ju; Chunli Zhou
Journal:  Int J Clin Exp Med       Date:  2015-12-15

8.  Escherichia coli isolates from inflammatory bowel diseases patients survive in macrophages and activate NLRP3 inflammasome.

Authors:  Marjorie De la Fuente; Luigi Franchi; Daniela Araya; David Díaz-Jiménez; Mauricio Olivares; Manuel Álvarez-Lobos; Douglas Golenbock; María-Julieta González; Francisco López-Kostner; Rodrigo Quera; Gabriel Núñez; Roberto Vidal; Marcela A Hermoso
Journal:  Int J Med Microbiol       Date:  2014-02-06       Impact factor: 3.473

9.  Dysbiosis in inflammatory bowel disease.

Authors:  C P Tamboli; C Neut; P Desreumaux; J F Colombel
Journal:  Gut       Date:  2004-01       Impact factor: 23.059

Review 10.  Recent advances in understanding enteric pathogenic Escherichia coli.

Authors:  Matthew A Croxen; Robyn J Law; Roland Scholz; Kristie M Keeney; Marta Wlodarska; B Brett Finlay
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.